Effect of dexmedetomidine with 0.75% ropivacaine in low volume superficial cervical plexus block with interscalene brachial plexus block for clavicular fixation surgeries

Efficacy of dexmedetomidine with 0.75% ropivacaine in low volume superficial cervical-interscalene brachial plexus block for clavicular fixation surgeries: a randomized double blind controlled trial.

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/02/063344

Enrollment

Registered

2024-02-29

Start date

Unknown

Completion date

Unknown

Last updated

2024-03-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: S420- Fracture of clavicle Health Condition 2: O- Medical and Surgical

Interventions

Intervention1: Ropivacaine with dexmedetomidine: Injection 0.75% Ropivacaine 12ml with 50microgram dexmedetomidine (0.5ml) is used for ultrasound guided Superficial Cervical-Interscalene block which i

Eligibility

Inclusion criteria

Inclusion criteria: Patients undergoing elective clavicle fixation surgeries

Exclusion criteria

Exclusion criteria: Patients with ASA III or more. Patient with severe cardiac illness. Patient with neurovascular injury. Patient with history of drug allergy. Patient with coagulopathies. Pregnant patient. Infection at the site of block placement. Emergency surgery. Patients with respiratory compromise. Patient refusal.

Design outcomes

Primary

Measure	Time frame
Duration of Analgesia in post operative periodTimepoint: 24 Hours	—

Secondary

Measure	Time frame
Onset of sensory blockade Onset of motor blockade Duration of sensory blockade Duration of motor blockade Any complicationsTimepoint: Immediately following the nerve blockade 24 hour postoperative	—

Countries

India

Contacts

Public ContactDr SABU KUMAR C L

Aarupadai Veedu Medical College and Hospital, Puducherry

bommidisrk@gmail.com9894723687

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026